Loading…
Tuesday November 17, 2026 1:40pm - 2:20pm GMT
  • Hear directly from pharma dealmakers on where they are prioritizing investment across therapeutics, modalities and stages of development 
  • Understand the key factors driving deal decisions, from scientific differentiation to data strength and strategic fit 
  • Learn what makes an asset, platform or company stand out in competitive partnering and M&A discussions 
  • Gain insight into how timing, structure and market dynamics influence deal execution in today’s environment
Speakers
avatar for Juergen Eckhardt

Juergen Eckhardt

Executive Vice President, Head of Business Development & Licensing (BD&L); Head of Leaps by Bayer, Bayer
Juergen Eckhardt is Executive Vice President at Bayer and Head of Business Development & Licensing (BD&L), as well as Head of Leaps by Bayer, the strategic investment unit of Bayer. He is a medical doctor and venture investor in healthcare, biotech, and agriculture with more than... Read More →
Tuesday November 17, 2026 1:40pm - 2:20pm GMT

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link